Ashwani Gujral of ashwanigujral.com is of the view that Ajanta Pharma can head to Rs 1950 and prefers Jubilant Life Sciences from the pharma space and feels that one can look at Ceat and MRF from the tyre space.
Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "In tyres, you had a four day rally. So, maybe not from a longer term perspective, but just for the day, it appears that they could show strength. So, both Ceat as well as MRF can be looked at."
"Ajanta Pharma has been through long correction. So, chances are that some amount of upside could be seen here. It could get back towards Rs 1,940-1,950," he said."Granules India, again, post the news on their facilities getting tested, etc. I think from here in a good market you will probably see Rs 143-145. However, my favourite midcap pharmaceutical stock is Jubilant Life Sciences. That has moved up from about Rs 650 to Rs 820 and again is showing strength today. So, try to look at these non-F&O stocks which are likely to do better," he added.